Skip to Main Content

KMAP BULLETIN: Preferred Drug List Update

Date: 09/09/22

KMAP GENERAL BULLETIN 22220 (PDF)

There is a Preferred Drug List (PDL) update effective September 1, 2022. Reference the Preferred Drug List page on the Kansas Department of Health and Environment (KDHE) website.

The following medications are now non-preferred and PDL Prior Authorization (PA) is now required:

  • Baclofen (Ozobax)
  • Benzoyl Peroxide (Epsolay®)
  • Celecoxib and Tramadol (Seglentis®)
  • Imiquimod (Zyclara)
  • Inclisiran (LeqvioR)
  • Levothyroxine (Tirosint®) (Capsule & Oral Solution)
  • Levothyroxine (Thyquidity)
  • Olopatadine (Pataday®) (0.7% drops)
  • Prenatal Vitamins: Prenate Elite, Primacare, Prenate Pixie, Prenate Mini, Prenate DHA, Citranatal Rx, Tristart DHA, OB Complete One, Nestabs, Westgel DHA, Nestabs DHA
  • Tezepelumab ekko (Tezspire)
  • Tretinoin and Benzoyl Peroxide (Twyneo®)
  • Vibegron (Gemtesa®)

Note: The effective date of the policy is September 1, 2022. The implementation of State policy by the KanCare Managed Care Organizations (MCOs) may vary from the date noted in the Kansas Medical Assistance Program (KMAP) bulletins. The KanCare Open Claims Resolution Log on the KMAP Bulletins page documents the MCO system status for policy implementation and any associated reprocessing completion dates once the policy is implemented.